PHS
AGIO icon

PFM Health Sciences’s Agios Pharmaceuticals AGIO Stock Holding History

PFM Health Sciences’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-614,506
Closed -$51.8M – 118
2018
Q2 		$51.8M Sell
614,506
-62,585
-9% -$5.46M 0.81% 46
2018
Q1 		$55.4M Buy
+677,091
New +$52.3M 1.13% 34
2014
Q4 		– Sell
-108,241
Closed -$6.64M – 90
2014
Q3 		$6.64M Buy
+108,241
New +$4.67M 0.15% 57
2013
Q4 		– Sell
-206,829
Closed -$5.78M – 63
2013
Q3 		$5.78M Buy
+206,829
New +$5.71M 0.14% 64

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

PFM Health Sciences's AGIO Position: Q3 2018 in Review

PFM Health Sciences sold out of Agios Pharmaceuticals (AGIO) in Q3 2018, closing a stake of 614,506 shares — an estimated $51.8M sold.

PFM Health Sciences first reported a position in AGIO in Q3 2013 and held it in 4 quarters. The position peaked at $55.4M in Q1 2018. 208 funds tracked by Wall St. Rank hold AGIO as of Q3 2018.

  • PFM Health Sciences reported no remaining Agios Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • PFM Health Sciences sold 614,506 Agios Pharmaceuticals shares in Q3 2018, an estimated $51.8M.
  • PFM Health Sciences first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • PFM Health Sciences's Agios Pharmaceuticals position peaked at $55.4M in Q1 2018.
  • 208 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2018.

Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.